Results
8
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
8 companies
Oscotec
Market Cap: ₩1.2t
Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.
A039200
₩30,750.00
7D
0.3%
1Y
7.0%
ALTEOGEN
Market Cap: ₩19.5t
A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.
A196170
₩376,000.00
7D
2.5%
1Y
113.4%
PharmaResearch
Market Cap: ₩3.7t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩362,500.00
7D
4.0%
1Y
187.5%
ABL Bio
Market Cap: ₩3.1t
A biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases.
A298380
₩64,900.00
7D
14.3%
1Y
185.9%
Macrogen
Market Cap: ₩175.6b
Provides precision medicine and bio-engineering healthcare services in Korea and internationally.
A038290
₩16,210.00
7D
3.9%
1Y
-18.0%
Seegene
Market Cap: ₩1.1t
Manufactures and sells molecular diagnostics products worldwide.
A096530
₩24,250.00
7D
2.5%
1Y
12.8%
Dong-A Socio Holdings
Market Cap: ₩631.6b
Engages in the pharmaceutical business in South Korea.
A000640
₩98,800.00
7D
0.6%
1Y
-12.2%
Daewon Pharmaceutical
Market Cap: ₩285.9b
A pharmaceutical company, manufactures and sells medicines and medical supplies in South Korea.
A003220
₩13,350.00
7D
1.4%
1Y
-9.6%